Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deep Breeze developed and commercialized a proprietary non-invasive, radiation-free pulmonary imaging system based on vibration response imaging. Their flagship product received FDA clearance in the US and was used globally in over 3,500 patients without adverse events by the late 2000s. The company later focused on telehealth solutions for chronic lung disease monitoring at home but faced challenges with commercialization and funding. There are no recent updates indicating ongoing operations or new products since the early-mid 2010s; thus it appears to be inactive or defunct.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deep Breeze.